ciprofloxacin has been researched along with oxadiazoles in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girija, D; Joy Hoskeri, H; Naik, HS; Sharath, N; Sudeep, HV; Vinay Kumar, B | 1 |
| Cao, TY; Duan, NN; Hou, LL; Hu, GQ; Huang, WL; Wang, GQ; Wang, W; Wen, XY; Xie, SQ; Yin, J | 1 |
| Phechkrajang, C; Prutthiwanasan, B; Suntornsuk, L | 1 |
| Huang, H; Ismail, I; Sun, H; Xi, Z; Xie, Y; Yi, L | 1 |
| Akhter, N; Ali Shah, SA; Anjum, F; Arshad, A; Aziz-Ur-Rehman, -; Bokhari, TH; Khan, SG; Rasool, S; Shahid, M | 1 |
| Ahmad Lone, B; Ahmad, F; Ahmad, N; Ali Khan, I; Ali, I; Grover, A; Khan, A; Kumari, A; Naaz, F; Rajput, VS; Shafi, S | 1 |
| Akhtar, R; Ali, KG; Gul Khan, S; Rasul, A; Zahoor, AF | 1 |
| Abdelazeem, AH; Cao, Y; Frejat, FOA; Gomaa, HAM; Wang, L; Wu, C; Youssif, BGM; Zhai, H | 1 |
8 other study(ies) available for ciprofloxacin and oxadiazoles
| Article | Year |
|---|---|
Synthesis and biological evaluation of new Tetra-aza macrocyclic scaffold constrained oxadiazole, thiadiazole and triazole rings.
Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Ciprofloxacin; DNA; DNA Replication; Macrocyclic Compounds; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Thiadiazoles; Triazoles | 2012 |
Part IV: Design, synthesis and antitumor activity of fluoroquinolone C-3 heterocycles: bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; CHO Cells; Ciprofloxacin; Cricetinae; Cricetulus; Drug Design; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia L1210; Molecular Structure; Oxadiazoles; Piperazine; Piperazines | 2012 |
Fluorescent labelling of ciprofloxacin and norfloxacin and its application for residues analysis in surface water.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Environmental Monitoring; Fluorescent Dyes; Fresh Water; Norfloxacin; Oxadiazoles; Reproducibility of Results; Thailand | 2016 |
A fluorogenic H
Topics: Air Pollutants; Amines; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Fluorescent Dyes; Hydrogen Sulfide; Optical Imaging; Oxadiazoles; Prodrugs; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2019 |
Synthesis, characterization, antibacterial, hemolytic and thrombolytic activity evaluation of 5-(3-chlorophenyl)-2-((N-(substituted)-2-acetamoyl)sulfanyl)-1,3,4-oxadiazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fibrinolytic Agents; Hemolysis; Microbial Sensitivity Tests; Oxadiazoles | 2020 |
1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Capsaicin; Cell Line, Tumor; Cell Survival; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Oxadiazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
In-vitro cytotoxic evaluation of newly designed ciprofloxacin-oxadiazole hybrids against human liver tumor cell line (Huh7).
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Ciprofloxacin; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Liver Neoplasms; Magnetic Resonance Spectroscopy; Oxadiazoles | 2021 |
New 1,2,4-oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Microbial Sensitivity Tests; Novobiocin; Oxadiazoles; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2022 |